You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Letter
Strontium and cardiovascular events
  1. Mark J Bolland,
  2. Andrew Grey
  1. Department of Medicine, University of Auckland, Auckland, New Zealand
  1. Correspondence to Mark J Bolland, Department of Medicine, University of Auckland, Auckland 1142, New Zealand; m.bolland{at}auckland.ac.nz

http://dx.doi.org/10.1136/annrheumdis-2013-203895

Statistics from Altmetric.com

    In the report of their trial of strontium ranelate in knee osteoarthritis, Reginster and colleagues state ‘Strontium ranelate was well tolerated’, and ‘The safety profile of strontium ranelate was satisfactory, in line …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

    Linked Articles